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to low concentrations of rifampin. To 
confirm that this effect was a result 
of persistence rather than generation 
of resistant mutants, we transferred 
the colonies growing after transient 
rifampin exposure of Beijing strain 
1585 to a medium containing 8 mg/L 
rifampin. Their growth was complete-
ly inhibited, and molecular analysis 
did not detect any of the most preva-
lent rifampin resistance–associated 
mutants (data not shown).
We believe that these results pro-
vide a possible explanation for the 
otherwise unrealistically high (ap-
parent) mutation frequency reported 
by de Steenwinkel et al. (2). If these 
strains are capable of persisting at 
low concentrations of rifampin, this 
extended period would provide a 
window for the generation of mutants 
during or after exposure. Stress may 
also play a role; rpoB gene mutants 
have shown to exhibit a stringent-like 
response (7), and defective rpoB ac-
tivity as a result of low-level rifampin 
exposure could induce a similar re-
sponse. If rifampin induces a stress 
response, the situation may be analo-
gous to the high mutation rates seen 
after quinolone exposure (8).
In summary, our data show that 
the high apparent M. tuberculosis strain 
mutation frequency reported by de 
Steenwinkel et al. (2) may be a result 
of the higher tolerance to rifampin of 
some Beijing strains. This tolerance 
likely results in a specific window of 
rifampin concentrations that, possibly 
combined with subsequent error-prone 
replication/outgrowth, enables the gen-
eration and selection of new mutants, 
rather than the selection of preexisting 
mutants. When interpreted in the light 
of our observations, the unexpected re-
sults of de Steenwinkel et al. could help 
explain the association of Beijing gen-
otype strains with drug resistance and 
relapse (9,10). Drug levels achieved 
during treatment may be much more 
critical in preventing the accumulation 
of rifampin-resistant mutants for these 
strains than for other genotypes.
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Bacteria in  
Dairy Products  
in Baggage  
of Incoming  
Travelers, Brazil
To the Editor: International air 
travel can lead to the rapid global 
dissemination of infectious agents. 
Unlike products and byproducts of 
animal origin imported between coun-
tries under agreements that legally 
establish sanitary standards, products 
introduced into a country illegally or 
irregularly do not follow specific stan-
dards and can come from any source, 
thereby posing a risk to the health 
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status of a country. Animal products 
transported clandestinely in baggage 
can contain infectious agents harm-
ful to animal and human health (1–4). 
We investigated Brucella spp., Myco-
bacterium bovis, and Mycobacterium 
avium subsp. paratuberculosis (MAP) 
in dairy products seized from baggage 
of passengers on flights at the 2 main 
international airports (Guarulhos Air-
port, São Paulo, and Galeão Airport, 
Rio de Janeiro) in Brazil.
During 2010–2011, 12 missions 
were instigated by the International 
Agriculture Surveillance (VIGIA-
GRO/MAPA) in airports to detect 
and seize unauthorized dairy products 
carried by passengers; 195 products 
were collected from multiple flights 
from different destinations. Baggage 
was scanned by using an x-ray ma-
chine and, on detection of a product, 
was opened by the owner in the pres-
ence of a federal agriculture inspector. 
To avoid contamination, the products 
were not opened and were sent to the 
designated Ministry of Agriculture, 
Livestock and Food Supply Labora-
tory in their original packaging. All 
seized products were packed accord-
ing to the International Air Transport 
Association standards (5) and trans-
ported by commercial aviation with 
official monitoring to the laboratory.
After completing real-time quan-
titative PCR (Promega, Madison, WI, 
USA) using TaqMan technology (Life 
Technologies, Darmstadt, Germany), 
we extracted DNA directly from the 
sample (6,7). The technique for the 
detection of MAP and eryD Brucella 
(except strain 19 Brucella abortus) 
and also using the region RD4 to de-
tect M. bovis were proposed by Irange 
et al. (8). To detect M. bovis, we used 
the primers M. bovis-88-F (5′-CGC.
CTT.CCT.AAC.CAG.AAT.TG-3′), 
M. bovis-88-R (5′-GGA.GAG.CGC.
CGT.TGT.AGG-3′) and to detect Bru-
cella, we used Bru-Eri-Taq-92-F (5′-
GCC.ACA.CTT.TCT.GCA.ATC.TG-
3′) and Bru-Eri-Taq-92-F (5′-GCG.
GTG.GAT.AAT.GAA.ATC.TGC-3′).
We analyzed 35 containers of 
dulce de leche, a caramelized milk 
paste confection, from Argentina (n = 
30), Angola (n = 1), and Uruguay (n 
= 4). We tested all specimens for Bru-
cella spp. and MAP, and 32 for M. bo-
vis. We detected MAP in 1 specimen 
from Argentina and 1 from Uruguay, 
Brucella spp. in 3 specimens from Ar-
gentina and 1 from Uruguay, and M. 
bovis in 1 specimen from Argentina.
Three containers of liquid milk 
from the United States were collected 
and analyzed for the presence of MAP; 
2 were analyzed for M. bovis and Bru-
cella. Brucella was detected in 1 speci-
men. Five containers of powdered milk 
were seized: 2 from Chile, 2 from An-
gola, and 1 from Portugal. Brucella 
was detected in 1 container from Chile; 
Brucella and M. bovis were found in 1 
container from Angola. Four contain-
ers of yogurt were seized, 1 each from 
the United States, China, Angola, and 
South Africa. MAP was detected in 
those from Angola and South Africa, 
and the yogurt from South Africa also 
showed Brucella.
We analyzed samples from 147 
cheeses that were confiscated from 
baggage owned by travelers from 21 
countries, mainly from Italy (24.5%), 
Portugal (22.4%), and France (14.3%). 
M. bovis was identified in 18 (17.5%) 
cheeses collected from Italy, Portugal, 
Spain, the United States, the Nether-
lands, Lebanon, Morocco, and Norway. 
MAP was amplified in specimens from 
13 cheeses from Spain, United States, 
Iraq, Israel, Norway, Peru, France, and 
Portugal, the last 2 countries showed 
the highest occurrence. Brucella was 
detected in 62 of the cheeses analyzed, 
which originated in Bolivia, Chile, 
Iraq, Lebanon, and Morocco (n = 1 in 
each country), Netherlands, Israel, and 
Norway (n = 2 in each country), Tur-
key and Spain (n = 3 in each country), 
United States, France and England (n 
= 4 in each country), Portugal (n=10), 
and Italy (n = 23).
Both M. bovis and Brucella were 
detected in 13 (8.8%) cheeses (1 each 
from Spain, Netherlands, Morocco, and 
Norway; 4 from Portugal, and 5 from 
Italy); Brucella and MAP were detect-
ed in 4 (2.7%) cheeses (Spain, France, 
Portugal, and Iraq). Co-amplification of 
the 3 genes (Brucella + MAP + M. bo-
vis) occurred in 3 (2%) cheeses (United 
States, Norway, and Portugal). Among 
the cheeses analyzed, 84 (57.1%) con-
tained isolates that amplified >1 of the 
genes for the 3 bacteria examined.
Of the 166 dairy products ana-
lyzed, Brucella was detected in 70 
(42.1%). Cheeses were the most 
seized products (n = 121) and had the 
highest number of Brucella-positive 
results (62/121[51.2%]). Brucella was 
detected in dairy products that origi-
nated in Argentina, Spain, France, 
Iraq, Israel, Italy, Lebanon, Portugal, 
and Turkey; it was detected in 4 (21%) 
of the 19 cheeses from France and in 
3 of the 4 (75%) cheeses that originat-
ed in Spain. M. bovis was detected in 
dulce de leche from Argentina, pow-
dered milk from Chile, and in cheeses 
from Spain, Netherlands, Italy, Leba-
non, Morocco, Norway, and Portugal.
Bacteria can be introduced into a 
country through contaminated animal 
products that are brought across bor-
ders illegally. The risk may be even 
greater when these products are car-
ried in passengers’ baggage on inter-
national flights because of the growing 
number of international travelers and 
the wide range of origins of these pas-
sengers. Greater attention should be 
given to agricultural surveillance at 
airports to mitigate the risk for intro-
duction of these products.
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To the Editor: Several clones 
of extended-spectrum β-lactamase 
(ESBL)–producing extraintestinal 
pathogenic Escherichia coli (ExPEC) 
have globally expanded their distribu-
tion, including multilocus sequence 
types (MLSTs) ST38, ST131, ST405, 
and ST648 (1). ExPEC infections often 
originate from the patient’s own intesti-
nal flora, although the degree of overlap 
between diarrheagenic E. coli and Ex-
PEC pathotypes is unclear. Relatively 
little is known about antimicrobial drug 
resistance in the most common diarrhe-
agenic E. coli groups, including entero-
aggregative E. coli (EAEC), and bacte-
rial gastroenteritis is generally managed 
without use of antimicrobial drugs.
The ability of diarrheagenic E. 
coli to cause extraintestinal infections 
has been shown in previous studies: 
a study among children in Nigeria 
linked EAEC to uropathogenic clon-
al group A (2), and a study in Brazil 
showed that EAEC markers were pres-
ent in 7.1% of the E. coli isolates from 
urinary tract infections (3). Neither of 
these studies identified clonal lineages 
of EAEC specifically associated with 
extraintestinal infections.
We conducted this study to estab-
lish the presence and characteristics 
of ESBL-producing EAEC in a well-
defined collection of ESBL-producing 
isolates (4). The isolates were from 
human and animal sources in Ger-
many, the Netherlands, and the United 
Kingdom. The study was conducted at 
Public Health England during Janu-
ary–April 2013.
DNA from 359 ESBL isolates 
(4) was screened for the presence of 
the EAEC transport regulator gene 
(aggR), located on the EAEC plasmid, 
by using a real-time PCR assay and the 






fication parameters were 50°C for 2 
min, 95°C for 2 min, and 40 cycles at 
95°C for 10 s and at 60°C for 20 s. Iso-
lates positive for aggR were confirmed 
to be E. coli by using the Omnilog Ge-
nIII MicroPlate (Biolog, Hayward, 
CA, USA). Serotyping was done by 
using standard methods (5).
The phylogroup was determined 
for each isolate, and isolates were then 
assigned to 1 of the 4 major E. coli 
groups: A, B1, B2, and D (6). A micro-
array was used to detect ESBL genes, 
such as blaCTX-M, at the group level, as 
previously described (4). The antimi-
crobial drug susceptibilities of EAEC 
isolates were determined by using the 
agar incorporation method, as described 
in the British Society for Antimicrobial 
Chemotherapy guidelines (7).
Virulence factors associated with 
intestinal and extraintestinal infection 
